Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter Ablation in Patients With Severe Mitral Regurgitation and Persistent Atrial Fibrillation
NCT06883864Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Apr 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Proportion of patients with residual mitral regurgitation of moderate [2+] or less at 12 months. Started Apr 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06883864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06883864.